292 related articles for article (PubMed ID: 33892721)
21. [Can meropenem E-test be used to estimate the presence of carbapenem resistance gene cfiA among Bacteroides fragilis strains?].
Toprak Ülger N; Ilki A; Ozel N; Balkan N; Söyletir G
Mikrobiyol Bul; 2011 Jul; 45(3):385-91. PubMed ID: 21935771
[TBL] [Abstract][Full Text] [Related]
22. Identification of two genetic groups in Bacteroides fragilis by multilocus enzyme electrophoresis: distribution of antibiotic resistance (cfiA, cepA) and enterotoxin (bft) encoding genes.
Gutacker M; Valsangiacomo C; Piffaretti JC
Microbiology (Reading); 2000 May; 146 ( Pt 5)():1241-1254. PubMed ID: 10832652
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of VITEK MS, Clin-ToF-II MS, Autof MS 1000 and VITEK 2 ANC card for identification of Bacteroides fragilis group isolates and antimicrobial susceptibilities of these isolates in a Chinese university hospital.
Wang Y; Chen XF; Xie XL; Xiao M; Yang Y; Zhang G; Zhang JJ; Duan SM; Zhang Q; Zhang P; Tsui C; Xu YC
J Microbiol Immunol Infect; 2019 Jun; 52(3):456-464. PubMed ID: 30772212
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneity in resistant fecal Bacteroides fragilis group collected from healthy people.
Narimani T; Douraghi M; Owlia P; Rastegar A; Esghaei M; Nasr B; Talebi M
Microb Pathog; 2016 Jun; 95():1-6. PubMed ID: 26945562
[TBL] [Abstract][Full Text] [Related]
25. Occurrence and analysis of rare cfiA-bft doubly positive Bacteroides fragilis strains.
Sóki J; Eitel Z; Terhes G; Nagy E; Urbán E;
Anaerobe; 2013 Oct; 23():70-3. PubMed ID: 23796697
[TBL] [Abstract][Full Text] [Related]
26. Genetic analysis of mechanisms of multidrug resistance in a clinical isolate of Bacteroides fragilis.
Pumbwe L; Wareham DW; Aduse-Opoku J; Brazier JS; Wexler HM
Clin Microbiol Infect; 2007 Feb; 13(2):183-189. PubMed ID: 17328731
[TBL] [Abstract][Full Text] [Related]
27. Susceptibility trends of Bacteroides fragilis group and characterisation of carbapenemase-producing strains by automated REP-PCR and MALDI TOF.
Treviño M; Areses P; Peñalver MD; Cortizo S; Pardo F; del Molino ML; García-Riestra C; Hernández M; Llovo J; Regueiro BJ
Anaerobe; 2012 Feb; 18(1):37-43. PubMed ID: 22261518
[TBL] [Abstract][Full Text] [Related]
28. Susceptibility to five antimicrobial agents of strains of the Bacteroides fragilis group isolated in Brazil.
De Almeida AE; De Uzeda M
Antimicrob Agents Chemother; 1987 Apr; 31(4):617-8. PubMed ID: 3649203
[TBL] [Abstract][Full Text] [Related]
29. Comparative evaluation of agar dilution and broth microdilution by commercial and in-house plates for Bacteroides fragilis group: An economical and expeditious approach for resource-limited settings.
Sood A; Angrup A; Ray P; Bala K
Anaerobe; 2021 Oct; 71():102443. PubMed ID: 34492368
[TBL] [Abstract][Full Text] [Related]
30. Synergism between penicillin, clindamycin, or metronidazole and gentamicin against species of the Bacteroides melaninogenicus and Bacteroides fragilis groups.
Brook I; Coolbaugh JC; Walker RI; Weiss E
Antimicrob Agents Chemother; 1984 Jan; 25(1):71-7. PubMed ID: 6142680
[TBL] [Abstract][Full Text] [Related]
31. Clinico-microbiological profile of
Gupta A; Shenoy PA; Kumar A; Chawla K
Indian J Med Res; 2021 May; 154(5):750-756. PubMed ID: 35532593
[TBL] [Abstract][Full Text] [Related]
32. Bacteroides fragilis group: trends in resistance.
Fille M; Mango M; Lechner M; Schaumann R
Curr Microbiol; 2006 Feb; 52(2):153-7. PubMed ID: 16450067
[TBL] [Abstract][Full Text] [Related]
33. [Activity of seven antimicrobial agents against "Bacteroides fragilis" (author's transl)].
Tytgat F
Ann Microbiol (Paris); 1980; 131(1):39-44. PubMed ID: 6899739
[TBL] [Abstract][Full Text] [Related]
34. First national survey of antibiotic susceptibility of the Bacteroides fragilis group: emerging resistance to carbapenems in Argentina.
Fernández-Canigia L; Litterio M; Legaria MC; Castello L; Predari SC; Di Martino A; Rossetti A; Rollet R; Carloni G; Bianchini H; Cejas D; Radice M; Gutkind G;
Antimicrob Agents Chemother; 2012 Mar; 56(3):1309-14. PubMed ID: 22232282
[TBL] [Abstract][Full Text] [Related]
35. Antibiotic resistance and adhesion potential of Bacteroides fragilis clinical isolates from Cape Town, South Africa.
Galvão BP; Meggersee RL; Abratt VR
Anaerobe; 2011 Aug; 17(4):142-6. PubMed ID: 21530667
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of antimicrobial resistance and the cfiA resistance gene in Danish Bacteroides fragilis group isolates since 1973.
Ferløv-Schwensen SA; Sydenham TV; Hansen KCM; Hoegh SV; Justesen US
Int J Antimicrob Agents; 2017 Oct; 50(4):552-556. PubMed ID: 28666749
[TBL] [Abstract][Full Text] [Related]
37. Development of EUCAST disk diffusion method for susceptibility testing of the Bacteroides fragilis group isolates.
Nagy E; Justesen US; Eitel Z; Urbán E;
Anaerobe; 2015 Feb; 31():65-71. PubMed ID: 25464140
[TBL] [Abstract][Full Text] [Related]
38. Emergence and evolution of an international cluster of MDR Bacteroides fragilis isolates.
Sóki J; Hedberg M; Patrick S; Bálint B; Herczeg R; Nagy I; Hecht DW; Nagy E; Urbán E
J Antimicrob Chemother; 2016 Sep; 71(9):2441-8. PubMed ID: 27246231
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial resistance, prevalence of resistance genes, and molecular characterization in intestinal Bacteroides fragilis group isolates.
Kouhsari E; Mohammadzadeh N; Kashanizadeh MG; Saghafi MM; Hallajzadeh M; Fattahi A; Ahmadi A; Niknejad F; Ghafouri Z; Asadi A; Boujary Nasrabadi MR
APMIS; 2019 Jun; 127(6):454-461. PubMed ID: 30803024
[TBL] [Abstract][Full Text] [Related]
40. Mechanisms of Bacteroides fragilis resistance to metronidazole.
Ghotaslou R; Bannazadeh Baghi H; Alizadeh N; Yekani M; Arbabi S; Memar MY
Infect Genet Evol; 2018 Oct; 64():156-163. PubMed ID: 29936037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
